School of Health Sciences, Caritas Institute of Higher Education, Tseung Kwan O, New Territories, Hong Kong.
Neuroscience Research Australia, School of Population Health, The University of New South Wales, Randwick, New South Wales, Australia.
Clin Respir J. 2021 Oct;15(10):1081-1087. doi: 10.1111/crj.13411. Epub 2021 Jul 6.
Dyspnoea-12 scale is a validated assessment tool, capturing the perception of dyspnoea and its physical and affective effects in individuals with chronic obstructive pulmonary disease (COPD). A validated version for the Chinese-speaking population has been unavailable.
To develop a Chinese version of D-12 (D-12-C) scale and evaluate its validity and reliability.
D-12 was translated from English to traditional Chinese in collaboration with a physician and a linguist. Back translation was adopted to ensure accuracy of the translation. A total of 155 COPD patients were recruited to test the reliability and validity of the D-12-C scale. Internal reliability and test-retest reliability were measured with Cronbach's alpha coefficient and intra-class correlation coefficient, respectively. Construct validity was assessed through exploratory factor analysis (EFA). Concurrent validity was assessed by the correlation of D-12-C total score and sub-scores and the Chinese version of Saint George's Respiratory Questionnaire (SGRQ), 36-Item Short Form Health Survey (SF-36), COPD Assessment Test (CAT) and Hospital Anxiety and Depression Scale (HADS) total score and sub-scores.
The two-factor structure of D-12-C was confirmed by EFA. D-12-C and its sub-scores demonstrated high level of internal reliability (Cronbach's alpha = 0.88) and moderate level of test-retest reliability. D-12-C total score, physical and affective sub-scores were significantly correlated to SGRQ total score (r = 0.59, p < 0.001) and activity sub-score (r = 0.38, p = 0.006), SF-36 mental health sub-score (r = -0.36, p < 0.001), CAT (r = 0.56, p < 0.001), HADS anxiety (r = 0.51, p < 0.001) and depression sub-scores (r = 0.44, p < 0.001).
D-12-C scale was developed, which demonstrated satisfactory reliability and validity in measuring dyspnoea among COPD patients.
呼吸困难-12 量表(Dyspnoea-12 scale)是一种经过验证的评估工具,可用于评估慢性阻塞性肺疾病(COPD)患者的呼吸困难感知及其身体和情感影响。目前还没有经过验证的中文版。
开发呼吸困难-12 量表中文版(D-12-C)并评估其有效性和可靠性。
D-12 量表由一位医生和一位语言学家合作从英文翻译成繁体中文。采用回译法确保翻译的准确性。共纳入 155 例 COPD 患者,以评估 D-12-C 量表的信度和效度。采用克朗巴赫 α 系数和组内相关系数分别评估内部信度和重测信度。采用探索性因子分析(EFA)评估结构效度。采用 D-12-C 总分和各分量表与圣乔治呼吸问卷(SGRQ)、36 项简明健康调查问卷(SF-36)、COPD 评估测试(CAT)和医院焦虑抑郁量表(HADS)总分和各分量表的相关性评估同时效度。
通过 EFA 确定了 D-12-C 的两因素结构。D-12-C 量表及其分量表具有较高的内部信度(克朗巴赫 α=0.88)和中等的重测信度。D-12-C 量表总分、躯体和情感分量表与 SGRQ 总分(r=0.59,p<0.001)和活动分量表(r=0.38,p=0.006)、SF-36 心理健康分量表(r=-0.36,p<0.001)、CAT(r=0.56,p<0.001)、HADS 焦虑分量表(r=0.51,p<0.001)和抑郁分量表(r=0.44,p<0.001)均呈显著相关性。
开发了呼吸困难-12 量表中文版,该量表在 COPD 患者呼吸困难的评估中具有良好的信度和效度。